Benzinga's Top Downgrades
Analysts at Raymond James downgraded Abbott Laboratories (NYSE: ABT) from “outperform” to “market perform.” Abbott's shares closed at $69.04 yesterday. Abbott's trailing-twelve-month ROA is 8.67%.
Analysts at Nomura downgraded Linear Technology (NASDAQ: LLTC) from “buy” to “neutral.” Linear Technology's shares closed at $32.22 yesterday. Linear Technology's PEG ratio is 4.54.
Analysts at Stephens downgraded Halliburton Company (NYSE: HAL) from “overweight” to “equal weight.” Halliburton's shares closed at $35.32 yesterday. Halliburton's trailing-twelve-month profit margin is 10.66%.
Goldman Sachs downgraded St. Jude Medical (NYSE: STJ) from “buy” to “neutral.” St. Jude Medical's shares closed at $40.85 yesterday. St. Jude Medical's trailing-twelve-month ROE is 17.25%.
Latest Ratings for ABT
|Jun 2016||Edward Jones||Upgrades||Hold||Buy|
|Apr 2016||Piper Jaffray||Downgrades||Overweight||Neutral|
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.